Quinolone resistance in clinical isolates of Serratia marcescens
- 1 May 1989
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (5) , 785-787
- https://doi.org/10.1128/aac.33.5.785
Abstract
The uptakes of norfloxacin by quinolone-resistant and -susceptible strains of Serratia marcescens were almost the same and 50% inhibitory concentrations for DNA gyrase and the MICs of quinolones were correlated, suggesting that DNA gyrase alterations are the basis of quinolone resistance.This publication has 19 references indexed in Scilit:
- Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacinAntimicrobial Agents and Chemotherapy, 1988
- Purification of Citrobacter freundii DNA gyrase and inhibition by quinolonesAntimicrobial Agents and Chemotherapy, 1988
- Norfloxacin resistance in a clinical isolate of Escherichia coliAntimicrobial Agents and Chemotherapy, 1987
- Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12Antimicrobial Agents and Chemotherapy, 1986
- In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivativeAntimicrobial Agents and Chemotherapy, 1986
- Emergence of Resistance to -Lactams, Aminoglycosides, and Quinolones During Combination Therapy for Infection Due to Serratia marcescensThe Journal of Infectious Diseases, 1986
- CIPROFLOXACIN-RESISTANT PSEUDOMONASThe Lancet, 1985
- CLINICAL RESISTANCE TO LONG-TERM ORAL CIPROFLOXACINThe Lancet, 1985
- Outer membrane permeation of beta-lactam antibiotics in Escherichia coli, Proteus mirabilis, and Enterobacter cloacaeAntimicrobial Agents and Chemotherapy, 1982
- Isolation of outer membrane proteins of Escherichia coli and their characterization on polyacrylamide gelBiochimica et Biophysica Acta (BBA) - Biomembranes, 1975